RadNet’s third quarter results were well received, with management attributing revenue and margin expansion to strong demand for advanced imaging services and operational improvements across its imaging centers. CEO Howard Berger highlighted the impact of investments in new PET/CT and MRI technology, increased capacity utilization, and a favorable shift toward higher-margin procedures. The expansion of joint ventures with health systems and robust growth in the Digital Health segment also contributed, with Berger noting that “cost-effective, freestanding outpatient imaging centers are essential to [health systems’] long-term strategies.”

Is now the time to buy RDNT? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from RadNet’s Q3 earnings call

• Brian Tanquilut (Jefferies) asked about the sustainability of advanced imaging growth and the impact of TechLive. CEO Howard Berger cited ongoing demand and technology investments, while CFO Mark Stolper detailed early but expanding adoption of TechLive for MRI efficiency.
• Clarke Murphy (Truist) inquired about operational efficiencies from digital scheduling and patient registration. COO Sham Sokka described productivity gains, noting that in some centers up to 75% of patients now register digitally, reducing front desk labor.
• Andrew Mok (Barclays) requested details on ONRAD’s earnout structure and 2027 guidance headwinds. Stolper explained the EBITDA-based earnout and highlighted growth from same-center volume, tuck-in acquisitions, and digital health ARR.
• Matthew Gillmor (KeyBanc) probed for details on capacity expansion’s contribution to advanced imaging growth. Stolper pointed to extended hours, new equipment, and accelerated center openings as major factors.
• Yuan Zhi (B. Riley Securities) questioned the margin outlook as AI adoption scales. Berger and Stolper emphasized cost containment from improved radiologist productivity and faster report turnaround, with additional service differentiation potential.

Catalysts in upcoming quarters

In the coming quarters, our team will be monitoring (1) the pace of advanced imaging volume growth and capacity utilization, (2) the integration and performance of the ONRAD acquisition, and (3) the continued expansion and monetization of the Digital Health segment’s AI and workflow solutions. We will also track developments in Medicare reimbursement and the rollout of digital registration tools across RadNet centers.

RadNet currently trades at $78.34, up from $76 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).

The best stocks for high-quality investors

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.